Supportive Cancer Care for Adults with Cancer

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Recruiting N/A Interventional Study
End of Life Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Health Services Research
Participants needed
2,996 (estimated)
Sponsor
Stanford University · Other
Who this trial is looking for

This trial is looking for adults who have been diagnosed with cancer or whose cancer has come back. Participants will compare two different ways of providing supportive care using technology and team-based approaches.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have a newly diagnosed solid tumor cancer or my cancer has come back.
  • I can understand and give my verbal consent.
  • I can speak English, Spanish, Chinese, or Vietnamese.

You may not be able to join if

  • I cannot consent to the study.
  • I plan to change my oncologist within the next 12 months.
  • I work for the practice site conducting the study.
  • I expect to move from the area within the next 12 months.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

This cluster-randomized comparative effectiveness trial compares a technology-based supportive cancer care (SCC) approach with a redesigned team-based supportive cancer care (SCC) approach.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Newly diagnosed patients with solid tumor cancer diagnosis or recurrence of the disease. 2. Patients must have the ability to understand and willingness to provide verbal consent. 3. Participants must speak English, Spanish, Chinese, or Vietnamese. Exclusion Criteria: 1. In…
Contacts

Manali I Patel, MD MPH MS

6507234000

manalip@stanford.edu

CONTACT